Lutherville, MD, United States of America

Dung Le

USPTO Granted Patents = 11 

Average Co-Inventor Count = 7.0

ph-index = 4

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Dung Le in Cancer Immunotherapy

Introduction

Dung Le, an accomplished inventor based in Lutherville, Maryland, has made significant strides in the field of cancer immunotherapy. With a remarkable portfolio of 11 patents to his name, Le is dedicated to advancing medical treatments that enhance patient outcomes. His work primarily revolves around breaking the immune tolerance that tumors create, ultimately promoting anti-tumor immunity.

Latest Patents

Dung Le's latest patents focus on breakthrough concepts in checkpoint blockade and microsatellite instability. His research suggests that blockade of immune checkpoints such as cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed death-1 (PD-1) can show promise in treating cancer patients. He details how inhibitory antibodies directed at these receptors can disrupt immune tolerance, thus enhancing anti-tumor responses. This approach is particularly effective for specific categories of tumors that produce numerous neoantigens, making them more susceptible to treatment.

Career Highlights

Le is currently associated with The Johns Hopkins University, an institution renowned for its commitment to research and medical innovation. His work in the field of immunotherapy has positioned him as an influential figure in the medical community. The impact of his patents continues to resonate within cancer research, offering hope for improved therapeutic strategies.

Collaborations

Dung Le has collaborated with esteemed colleagues such as Luis Diaz and Bert Vogelstein. These partnerships amplify the potential of his research, creating a synergistic environment for innovation. Together, they are dedicated to pushing the boundaries of what is possible in cancer treatment.

Conclusion

In summary, Dung Le's contributions to cancer immunotherapy through his patents and collaborations represent a significant advancement in the fight against cancer. His research continues to pave the way for innovative treatments, ultimately aiming to improve the lives of patients battling this formidable disease. As he progresses in his career, the scientific community eagerly anticipates the future discoveries that will emerge from his work.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…